Projects

Director of the Institute of Experimental Pharmacology and Toxicology, Member of the Executive Board - CEM
Dr.rer.nat., Ing. Helena Kanďárová, ERT

International

Current
  • 3Rs concepts to improve the quality of biomedical science (IMPROVE)
    Program: COST
    Duration: 21. 10. 2022 – 20. 10. 2026
  • Engineering novel 3D organotypic skin models
    Program: COST
    Duration: 15. 9. 2022 – 14. 9. 2026
  • Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment
    Program: Horizon 2020
    Duration: 1. 5. 2021 – 30. 4. 2026
  • Exploration of toxicology properties of drug candidates with antimicrobial and antiviral properties.
    Program: Multilateral - other
    Duration: 1. 9. 2024 – 31. 12. 2025
  • EU-NETVAL International Thyroid Validation Study
    Program: Multilateral - other
    Duration: 1. 1. 2021 – 31. 12. 2024
Finished
  • Training Network for improving of safety of medical devices - focus on oral cavity
    Program: Multilateral - other
    Duration: 1. 1. 2020 – 31. 12. 2022

National

Finished
  • In vitro biocompatibility testing of medical devices (MDs) and new generation bio-materials for MDs
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
  • Bio-compatibility assessment of medical devices and novel medical device materials using in vitro methods based on 3D reconstructed human tissue models.
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Toxicology and pharmacology for everyone: How to protect yourself from risks in the 21st century
    Program: Other projects
    Duration: 1. 5. 2023 – 31. 12. 2023
  • Development of products by modification of natural compounds and study of their multi-modal effects onCOVID-19 disease
    Program:
    Duration: 1. 7. 2021 – 30. 6. 2023
  • Training Network for improving of safety of medical devices - focus on oral cavity
    Program: SRDA
    Duration: 1. 3. 2020 – 31. 12. 2022
Employees